Helus Pharma Reports Second Quarter Fiscal 2027 Financial Results and Recent Business Highlights
Appointed Michael Halstead as Chief Executive Officer to lead Helus Pharma through late-stage development and commercialization
Appointed Michael Halstead as Chief Executive Officer to lead Helus Pharma through late-stage development and commercialization